Chronometric TMS-fMRI of personalized left dorsolateral prefrontal target reveals state-dependency of subgenual anterior cingulate cortex effects
- PMID: 38532009
- PMCID: PMC11420068
- DOI: 10.1038/s41380-024-02535-3
Chronometric TMS-fMRI of personalized left dorsolateral prefrontal target reveals state-dependency of subgenual anterior cingulate cortex effects
Abstract
Transcranial magnetic stimulation (TMS) applied to a left dorsolateral prefrontal cortex (DLPFC) area with a specific connectivity profile to the subgenual anterior cingulate cortex (sgACC) has emerged as a highly effective non-invasive treatment option for depression. However, antidepressant outcomes demonstrate significant variability among therapy plans and individuals. One overlooked contributing factor is the individual brain state at the time of treatment. In this study we used interleaved TMS-fMRI to investigate the influence of brain state on acute TMS effects, both locally and remotely. TMS was performed during rest and during different phases of cognitive task processing. Twenty healthy participants were included in this study. In the first session, imaging data for TMS targeting were acquired, allowing for identification of individualized targets in the left DLPFC based on highest anti-correlation with the sgACC. The second session involved chronometric interleaved TMS-fMRI measurements, with 10 Hz triplets of TMS administered during rest and at distinct timings during an N-back task. Consistent with prior findings, interleaved TMS-fMRI revealed significant BOLD activation changes in the targeted network. The precise timing of TMS relative to the cognitive states during the task demonstrated distinct BOLD response in clinically relevant brain regions, including the sgACC. Employing a standardized timing approach for TMS using a task revealed more consistent modulation of the sgACC at the group level compared to stimulation during rest. In conclusion, our findings strongly suggest that acute local and remote effects of TMS are influenced by brain state during stimulation. This study establishes a basis for considering brain state as a significant factor in designing treatment protocols, possibly improving TMS treatment outcomes.
© 2024. The Author(s).
Conflict of interest statement
NW is a named inventor on Stanford-owned intellectual property relating to accelerated TMS pulse pattern sequences and neuroimaging-based TMS targeting; he has served on scientific advisory boards for Otsuka, NeuraWell, Nooma, and Halo Neuroscience; and he has equity/stock options in Magnus Medical, NeuraWell, and Sooma. The other authors have no conflicts of interest to declare.
Figures




Similar articles
-
Subgenual cingulate connectivity as a treatment predictor during low-frequency right dorsolateral prefrontal rTMS: A concurrent TMS-fMRI study.Brain Stimul. 2023 Jul-Aug;16(4):1165-1172. doi: 10.1016/j.brs.2023.07.051. Epub 2023 Aug 3. Brain Stimul. 2023. PMID: 37543171
-
Dose-Dependent Target Engagement of a Clinical Intermittent Theta Burst Stimulation Protocol: An Interleaved Transcranial Magnetic Stimulation-Functional Magnetic Resonance Imaging Study in Healthy People.Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Aug;10(8):804-813. doi: 10.1016/j.bpsc.2024.08.009. Epub 2024 Aug 25. Biol Psychiatry Cogn Neurosci Neuroimaging. 2025. PMID: 39182723
-
Neural response during prefrontal theta burst stimulation: Interleaved TMS-fMRI of full iTBS protocols.Neuroimage. 2024 May 1;291:120596. doi: 10.1016/j.neuroimage.2024.120596. Epub 2024 Mar 29. Neuroimage. 2024. PMID: 38554783
-
Mechanisms of Action of TMS in the Treatment of Depression.Curr Top Behav Neurosci. 2024;66:233-277. doi: 10.1007/7854_2024_483. Curr Top Behav Neurosci. 2024. PMID: 38844713 Review.
-
Enhancing ventrolateral prefrontal cortex activation mitigates social pain and modifies subsequent social attitudes: Insights from TMS and fMRI.Neuroimage. 2024 Apr 15;292:120620. doi: 10.1016/j.neuroimage.2024.120620. Epub 2024 Apr 18. Neuroimage. 2024. PMID: 38641257 Review.
Cited by
-
Antidepressant efficacy of administering repetitive transcranial magnetic stimulation (rTMS) with psychological and other non-pharmacological methods: a scoping review and meta-analysis.Psychol Med. 2025 Feb 27;55:e64. doi: 10.1017/S0033291725000315. Psychol Med. 2025. PMID: 40012529 Free PMC article.
-
Quality over quantity: powering neuroimaging samples in psychiatry.Neuropsychopharmacology. 2024 Nov;50(1):58-66. doi: 10.1038/s41386-024-01893-4. Epub 2024 Jun 20. Neuropsychopharmacology. 2024. PMID: 38902353 Review.
-
Identification of Cortical Targets for Modulating Function Supported by the Human Hippocampal Network.Hum Brain Mapp. 2025 Apr 1;46(5):e70167. doi: 10.1002/hbm.70167. Hum Brain Mapp. 2025. PMID: 40202284 Free PMC article.
-
Novel NIBS in psychiatry: Unveiling TUS and TI for research and treatment.Brain Neurosci Adv. 2025 Mar 14;9:23982128251322241. doi: 10.1177/23982128251322241. eCollection 2025 Jan-Dec. Brain Neurosci Adv. 2025. PMID: 40092509 Free PMC article. Review.
-
Boosting Psychotherapy With Noninvasive Brain Stimulation: The Whys and Wherefores of Modulating Neural Plasticity to Promote Therapeutic Change.Neural Plast. 2024 Dec 18;2024:7853199. doi: 10.1155/np/7853199. eCollection 2024. Neural Plast. 2024. PMID: 39723244 Free PMC article. Review.
References
-
- Cole EJ, Stimpson KH, Bentzley BS, Gulser M, Cherian K, Tischler C, et al. Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression. AJP. 2020;177:716–26. - PubMed
-
- Cole EJ, Phillips AL, Bentzley BS, Stimpson KH, Nejad R, Barmak F, et al. Stanford neuromodulation therapy (SNT): a double-blind randomized controlled trial. AJP. 2022;179:132–41. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical